This randomised clinical trial will determine whether fluid therapy with Plasma-Lyte® 148 reduces the number of days in hospital compared to treatment with 0.9% sodium chloride in ED patients presenting with moderate-severe diabetic ketoacidosis.
This randomised clinical trial will determine whether fluid therapy with Plasma-Lyte® 148 reduces the number of days in hospital compared to treatment with 0.9% sodium chloride in ED patients presenting with moderate-severe diabetic ketoacidosis.